The hepatitis C virus epidemic in Cameroon: Genetic evidence for rapid transmission between 1920 and 1960

Infection, Genetics and Evolution

Volumn 7, Issue 3, 2007, Pages 361-367

  Njouom, Richard ^a   Nerrienet, Eric ^a   Dubois, Martine ^c   Lachenal, Guillaume ^b   Rousset, Dominique ^a   Vessière, Aurelia ^a   Ayouba, Ahidjo ^a   Pasquier, Christophe ^c   Pouillot, Régis ^a  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CHU PURPAN   (France)

Author keywords

Bayesian inference; Cameroon; Epidemic history; HCV; Iatrogenic transmission

Indexed keywords

HEPATITIS C VACCINE;

ARTICLE; CAMEROON; EPIDEMIC; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GROWTH RATE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POPULATION RESEARCH; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RISK ASSESSMENT; TRYPANOSOMIASIS; UNINDEXED SEQUENCE; VIROGENESIS; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

BAYES THEOREM; CAMEROON; DISEASE OUTBREAKS; ENDEMIC DISEASES; EPIDEMIOLOGY, MOLECULAR; HEPACIVIRUS; HEPATITIS C; HISTORY, 20TH CENTURY; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PREVALENCE; VARIATION (GENETICS);

HEPATITIS C VIRUS;

EID: 34247615493     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2006.10.003     Document Type: Article

References (64)

1. Beaudiment R., and Leproux P. Incidence de la lomidinisation sur la régression de la trypanosomiase au Cameroun français. Med. Trop. 13 (1953) 949-954
2. Bukh J., Purcell R., and Miller R. At least 12 genotypes of Hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. PNAS 90 17 (1993) 8234
3. Candotti D., Temple J., Sarkodie F., and Allain J.-P. Frequent recovery and broad genotype 2 diversity characterize Hepatitis C virus infection in Ghana, West Africa. J. Virol. 77 14 (2003) 7914-7923
4. Cochrane A., Searle B., Hardie A., Robertson R., Delahooke T., Cameron S., Tedder R., Dusheiko G., De Lamballerie X., and Simmonds P. A genetic analysis of hepatitis C virus transmission between injection drug users. J. Infect. Dis. 186 9 (2002) 1212-1221
5. Delaporte E., Froment A., Dazza M., Henzel D., and Larouze B. Hepatitis C in remote populations of southern Cameroon. Ann. Trop. Med. Parasitol. 88 1 (1994) 97-98
6. Donnelly P., and Tavare S. Coalescents and genealogical structure under neutrality. Annu. Rev. Genet. 29 (1995) 401-421
7. Drucker E., Alcabes P., and Marx P. The injection century: massive unsterile injections and the emergence of human pathogens. Lancet 358 (2001) 1989-1992
8. Drummond A., Pybus O., and Rambaut A. Inference of viral evolutionary rates from molecular sequences. Adv. Parasitol. 54 (2003) 331-358
9. Drummond A.J., Rambaut A., Shapiro B., and Pybus O.G. Bayesian coalescent inference of past population dynamics from molecular sequences. Mol. Biol. Evol. 22 5 (2005) 1185-1192
10. Frank C., Mohamed M., Strickland G., Lavanchy D., Arthur R., Magder L., El Khoby T., Abdel-Wahab Y., Aly Ohn E., Anwar W., and Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355 9207 (2000) 887-891
11. Fretz C., Jeannel D., Stuyver L., Herve V., Lunel F., Boudifa A., Mathiot C., De The G., and Fournel J. HCV infection in a rural population of the Central African Republic (CAR): evidence for three additional subtypes of genotype 4. J. Med. Virol. 47 4 (1995) 435-437
12. Gall D. The chemoprophylaxis of sleeping sickness with the diamidines. Ann. Trop. Med. Parasitol. 48 (1954) 242-258
13. Gisselquist D. Emergence of the HIV type 1 epidemic in the twentieth century: comparing hypotheses to evidence. AIDS Res. Hum. Retroviruses 19 12 (2003) 1071-1078
14. Guindon S., and Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52 (2003) 696-704
15. Hasegawa M., Kishino H., and Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J. Mol. Evol. 22 2 (1985) 160-174
16. Hue S., Pillay D., Clewley J.P., and Pybus O.G. Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups. PNAS 102 12 (2005) 4425-4429
17. Ihaka R., and Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5 (1996) 299-314
18. Jamot E. La maladie du sommeil au Cameroun en janvier 1929. Bull. Soc. Pathol. Exot. 22 (1929) 473-496
19. Jeannel D., Fretz C., Traore Y., Kohdjo N., Bigot A., Pe Gamy E., Jourdan G., Kourouma K., Maertens G., Fumoux F., Fournel J., and Stuyver L. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J. Med. Virol. 55 2 (1998) 92-97
20. Joy D.A., Feng X., Mu J., Furuya T., Chotivanich K., Krettli A.U., Ho M., Wang A., White N.J., Suh E., Beerli P., and Su X.-z. Early origin and recent expansion of Plasmodium falciparum. Science 300 5617 (2003) 318-321
21. Kemmegne J., Bania D., and Louis F. Hepatitis C seropositivity after multiple transfusions in sickle cell anemia patients in Yaounde Cameroon. Med. Trop. (Mars.) 56 3 (1996) 309-310
22. Kowo M., Goubau P., Ndam E., Njoya O., Sasaki S., Seghers V., and Kesteloot H. Prevalence of hepatitis C virus and other blood-borne viruses in Pygmies and neighbouring Bantus in southern Cameroon. Trans. R. Soc. Trop. Med. Hyg. 89 5 (1995) 484-486
23. Lanave C., Preparata G., Saccone C., and Serio G. A new method for calculating evolutionary substitution rates. J. Mol. Evol. 20 1 (1984) 86-93
24. Lemey P., Pybus O., Van Dooren S., and Vandamme A. A Bayesian statistical analysis of human T-cell lymphotropic virus evolutionary rates. Infect. Genet. Evol. 5 3 (2005) 291-298
25. Lemey P., Pybus O.G., Rambaut A., Drummond A.J., Robertson D.L., Roques P., Worobey M., and Vandamme A.-M. The molecular population genetics of HIV-1 Group O. Genetics 167 3 (2004) 1059-1068
26. Lemey P., Pybus O.G., Wang B., Saksena N.K., Salemi M., and Vandamme A.-M. Tracing the origin and history of the HIV-2 epidemic. PNAS 100 11 (2003) 6588-6592
27. Louis F., Maubert B., Le Hesran J., Kemmegne J., Delaporte E., and Louis J. High prevalence of anti-hepatitis C virus antibodies in a Cameroon rural forest area. Trans. R. Soc. Trop. Med. Hyg. 88 1 (1994) 53-54
28. Madhava V., Burgess C., and Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect. Dis. 2 5 (2002) 293-302
29. Menendez C., Sanchez-Tapias J.-M., Alonso P.-L., Gimenez-Barcons M., Kahigwa E., Aponte J.-J., Mshinda H., Navia M.-M., Jimenez de Anta M.-T., Rodes J., and Saiz J.-C. Molecular evidence of mother-to-infant transmission of Hepatitis G virus among women without known risk factors for parenteral infections. J. Clin. Microbiol. 37 7 (1999) 2333-2336
30. Nakano T., Lu L., Liu P., and Pybus O. Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J. Infect. Dis. 190 6 (2004) 1098-1108
31. Ndjomou J., Kupfer B., Kochan B., Zekeng L., Kaptue L., and Matz B. Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon. J. Med. Virol. 66 2 (2002) 179-186
32. Ndjomou J., Pybus O.G., and Matz B. Phylogenetic analysis of hepatitis C virus isolates indicates a unique pattern of endemic infection in Cameroon. J. Gen. Virol. 84 9 (2003) 2333-2341
33. Ndumbe P., and Skalsky J. Hepatitis C virus infection in different populations in Cameroon. Scand. J. Infect. Dis. 25 6 (1993) 689-692
34. Nerrienet E., Pouillot R., Lachenal G., Njouom R., Mfoupouendoun J., Bilong C., Pasquier C., and Ayouba A. Hepatitis C virus infection in Cameroon: a cohort-effect. J. Med. Virol. 76 (2005) 208-214
35. Njouom R., Pasquier C., Ayouba A., Gessain A., Froment A., Mfoupouendoun J., Pouillot R., Dubois M., Sandres-Saune K., Thonnon J., Izopet J., and Nerrienet E. High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon. J. Med. Virol. 71 2 (2003) 219-225
36. Njouom R., Pasquier C., Ayouba A., Sandres-Saune K., Mfoupouendoun J., Mony Lobe M., Tene G., Thonnon J., Izopet J., and Nerrienet E. Hepatitis C virus infection among pregnant women in Yaounde, Cameroon: prevalence, viremia, and genotypes. J. Med. Virol. 69 3 (2003) 384-390
37. Njouom R., Pasquier C., Ayouba A., Tejiokem M., Vessiere A., Mfoupouendoun J., Tene G., Eteki N., Monny lobe M., Izopet J., and Nerrienet E. Low risk of mother to child transmission, of hepatitis C virus in Yaounde, Cameroon: the ANRS 1262 study. Am. J. Trop. Med. Hyg. 73 2 (2005) 460-466
38. Nkengasong J., Nyambi P., Claeys H., De Beenhouwer H., Collart J., Ayuk J., and Ndumbe P. Predominantly hepatitis C virus genotypes 1 and 2 are found in Cameroon. J. Infect. Dis. 171 5 (1995) 1380-1381
39. Opgen-Rhein R., Fahrmeir L., and Strimmer K. Inference of demographic history from genealogical trees using reversible jump Markov chain Monte Carlo. BMC Evol. Biol. 5 1 (2005) 6
40. Paradis E., Claude J., and Strimmer K. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 20 (2004) 289-290
41. Pasquier C., Njouom R., Ayouba A., Dubois M., Sartre M., Vessiere A., Timba I., Thonnon J., Izopet J., and Nerrienet E. Distribution and heterogeneity of hepatitis C genotypes in hepatitis patients in Cameroon. J. Med. Virol. 77 3 (2005) 390-398
42. Pybus O., Cochrane A., Holmes E., and Simmonds P. The hepatitis C virus epidemic among injecting drug users. Infect. Genet. Evol. 5 2 (2005) 131-139
43. Pybus O.G., Charleston M.A., Gupta S., Rambaut A., Holmes E.C., and Harvey P.H. The epidemic behavior of the Hepatitis C virus. Science 292 5525 (2001) 2323-2325
44. Pybus O.G., Drummond A.J., Nakano T., Robertson B.H., and Rambaut A. The epidemiology and iatrogenic transmission of Hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol. Biol. Evol. 20 3 (2003) 381-387
45. Pybus O.G., and Rambaut A. GENIE: estimating demographic history from molecular phylogenies. Bioinformatics 18 10 (2002) 1404-1405
46. Pybus O.G., Rambaut A., and Harvey P.H. An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155 3 (2000) 1429-1437
47. Rambaut A., Robertson D., Pybus O., Peeters M., and Holmes E. Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 410 6832 (2001) 1047-1048
48. Rao M., Naficy A., Darwish M., Darwish N., Schisterman E., Clemens J., and Edelman R. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect. Dis. 2 1 (2002) 29
49. Robbins K.E., Lemey P., Pybus O.G., Jaffe H.W., Youngpairoj A.S., Brown T.M., Salemi M., Vandamme A.-M., and Kalish M.L. U.S. human immunodeficiency virus Type 1 epidemic: date of origin, population history, and characterization of early strains. J. Virol. 77 11 (2003) 6359-6366
50. Ruggieri A., Argentini C., Kouruma F., Chionne P., D'Ugo E., Spada E., Dettori S., Sabbatani S., and Rapicetta M. Heterogeneity of hepatitis C virus genotype 2 variants in West Central Africa (Guinea Conakry). J. Gen. Virol. 77 9 (1996) 2073-2076
51. Salemi M., and Vandamme A.M. Hepatitis C virus evolutionary patterns studied through analysis of full-genome sequences. J. Mol. Evol. 54 1 (2002) 62-70
52. Schmidt H.A., Strimmer K., Vingron M., and von Haeseler A. TREE-PUZZLE: maximum likelihood phylogenetic analysis using quartets and parallel computing. Bioinformatics 18 3 (2002) 502-504
53. Simmonds P. 2000 Fleming lecture. The origin and evolution of hepatitis viruses in humans. J. Gen. Virol. 82 4 (2001) 693-712
54. Simmonds P. Reconstructing the origins of human hepatitis viruses. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 1411 (2001) 1013-1026
55. Simmonds P. Genetic diversity and evolution of hepatitis C virus-15 years on. J. Gen. Virol. 85 11 (2004) 3173-3188
56. Strimmer K., and Pybus O.G. Exploring the demographic history of DNA sequences using the generalized Skyline Plot. Mol. Biol. Evol. 18 12 (2001) 2298-2305
57. Tanaka Y., Agha S., Saudy N., Kurbanov F., Orito E., Kato T., Abo-Zeid M., Khalaf M., Miyakawa Y., and Mizokami M. Exponential spread of hepatitis C virus genotype 4a in Egypt. J. Mol. Evol. 58 2 (2004) 191-195
58. Tanaka Y., Hanada K., Mizokami M., Yeo A.E.T., Shih J.W.-K., Gojobori T., and Alter H.J. Inaugural article: a comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. PNAS 99 24 (2002) 15584-15589
59. Thompson J., Gibson T., Plewniak F., Jeanmougin F., and Higgins D. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 24 (1997) 4876-4882
60. Van Dooren S., Pybus O.G., Salemi M., Liu H.-F., Goubau P., Remondegui C., Talarmin A., Gotuzzo E., Alcantara L.C.J., Galvao-Castro B., and Vandamme A.-M. The low evolutionary rate of human T-cell lymphotropic virus Type-1 confirmed by analysis of vertical transmission chains. Mol. Biol. Evol. 21 3 (2004) 603-611
61. Walker P., Pybus O., Rambaut A., and Holmes E. Comparative population dynamics of HIV-1 subtypes B and C: subtype-specific differences in patterns of epidemic growth. Infect. Genet. Evol. 5 3 (2005) 199-208
62. Wansbrough-Jones M., Frimpong E., Cant B., Harris K., Evans M., and Teo C. Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana. Trans. R. Soc. Trop. Med. Hyg. 92 5 (1998) 496-499
63. Xu L., Larzul D., Delaporte E., Brechot C., and Kremsdorf D. Hepatitis C virus genotype 4 is highly prevalent in central Africa (Gabon). J. Gen. Virol. 75 9 (1994) 2393-2398
64. Yusim K., Peeters M., Pybus O., Bhattacharya T., Delaporte E., Mulanga C., Muldoon M., Theiler J., and Korber B. Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution. Philos. Trans. R. Soc. Lond. B Biol. Sci. 356 1410 (2001) 855-866